QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
CVE:LTY

Liberty Biopharma (LTY) Stock Forecast, Price & News

C$2.00
+2.00 (+∞)
(As of 10/10/2018)
Compare
Today's Range
C$2.00
▼
C$2.00
50-Day Range
C$2.00
▼
C$2.00
52-Week Range
C$0.06
▼
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlines

LTY stock logo

About Liberty Biopharma (CVE:LTY) Stock

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

May 21, 2023 | americanbankingnews.com
Liberty Biopharma (CVE:LTY) Share Price Crosses Below Two Hundred Day Moving Average of $2.00
May 21, 2023 | msn.com
Wash Out; Liberty Hexed by Mystics in 2023 Debut
May 30, 2023 | Edge On The Street (Ad)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
May 17, 2023 | marketwatch.com
LIBERTY SPORTS GROUP PARTNERS WITH CHEQ TO ELEVATE THE GAMEDAY EXPERIENCE
May 15, 2023 | benzinga.com
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023
May 14, 2023 | investing.com
Intech Biopharm Ltd (6461)
May 13, 2023 | investing.com
Liberty Defense Holdings Ltd (LDDFF)
May 12, 2023 | investing.com
Lepu Biopharma Co Ltd (2157)
May 30, 2023 | Edge On The Street (Ad)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
May 11, 2023 | msn.com
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
May 10, 2023 | finanznachrichten.de
YS BIOPHARMA CO LTD
May 9, 2023 | benzinga.com
Liberty TripAdvisor Holdings, Inc. to Hold Virtual Annual Meeting of Stockholders
May 8, 2023 | forbes.com
Liberty Mutual Pet Insurance Review 2023
May 8, 2023 | reuters.com
Baxter to divest biopharma business for $4.25 billion
May 3, 2023 | marketwatch.com
Microbot Medical's LIBERTY(R) Robotic System Surpasses 100th Catheterization
April 30, 2023 | msn.com
Liberty boosts its life unit with Sh130 million capital
April 25, 2023 | msn.com
Xeris Biopharma Holdings (STU:2B30) Price Target Decreased by 7.84% to 4.33
April 20, 2023 | msn.com
Liberty Water Invests $265 Million In Last 5 Years For Infrastructure
April 14, 2023 | forbes.com
Liberty Home Guard Review 2023
April 9, 2023 | americanbankingnews.com
Liberty Biopharma (CVE:LTY) Stock Crosses Below 200 Day Moving Average of $2.00
February 28, 2023 | msn.com
Explore Two American Landmarks When You Visit The Statue Of Liberty & Ellis Island In New York
February 26, 2023 | msn.com
Guide to Visiting the Statue of Liberty
February 9, 2023 | yahoo.com
'Moms for Liberty' calls on lawmakers to help get 'inappropriate' books out of Iowa schools
February 7, 2023 | yahoo.com
'Moms for Liberty' calls for lawmakers to get 'inappropriate' books out of Iowa schools
February 2, 2023 | msn.com
Liberty Twp. Hampton Inn sold to S.C. company
January 27, 2023 | bizjournals.com
Sale price leaps by $20M for repurposed Durham warehouse
November 1, 2022 | msn.com
How a Maryland ‘Moms for Liberty' group became leaders in our country's culture war
See More Headlines
Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:LTY
Previous Symbol
CVE:VVA
CUSIP
N/A
CIK
N/A
Web
www.libertybiopharma.com
Phone
+1-604-3777575
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
8.19
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
2,000.00
Book Value
C$0.79 per share
Price / Book
2.53

Miscellaneous

Outstanding Shares
10,770,000
Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Norman Tsui (Age 45)
    Pres, CEO & Director
  • Mr. Shui Yan Tam (Age 44)
    Chief Financial Officer
  • Dr. Michael T. McNamara
    Medical Advisor & Director
  • Dr. Richard Huang Ph.D. (Age 42)
    Chief Technology Officer
  • Dr. Richard Cook M.D.
    Msc., FRCSC, Chief Medical Officer

Key Competitors

View All Competitors













LTY Stock - Frequently Asked Questions

How have LTY shares performed in 2023?

Liberty Biopharma's stock was trading at C$2.00 at the beginning of the year. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Liberty Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC).

What is Liberty Biopharma's stock symbol?

Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY."

How do I buy shares of Liberty Biopharma?

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Liberty Biopharma's stock price today?

One share of LTY stock can currently be purchased for approximately C$2.00.

How much money does Liberty Biopharma make?

Liberty Biopharma (CVE:LTY) has a market capitalization of C$21.54 million.

How can I contact Liberty Biopharma?

Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The official website for the company is www.libertybiopharma.com. The biotechnology company can be reached via phone at +1-604-3777575.

This page (CVE:LTY) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -